Naltrexone
"Naltrexone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
| Descriptor ID |
D009271
|
| MeSH Number(s) |
D03.132.577.249.706.550 D03.549.686.750.550 D03.605.497.750.550 D04.615.723.795.706.550
|
| Concept/Terms |
Celupan- Celupan
- Lacer Brand of Naltrexone Hydrochloride
ReVia- ReVia
- Du Pont Brand of Naltrexone Hydrochloride
- Lamepro Brand of Naltrexone Hydrochloride
- United Drug Brand of Naltrexone Hydrochloride
- Nemexin
- Orphan Brand of Naltrexone Hydrochloride
- Schering-Plough Brand of Naltrexone Hydrochloride
- Schering Plough Brand of Naltrexone Hydrochloride
- Bristol-Myers Squibb Brand of Naltrexone Hydrochloride
- Bristol Myers Squibb Brand of Naltrexone Hydrochloride
- Nalorex
Antaxone- Antaxone
- Pharmazam Brand of Naltrexone Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Naltrexone".
Below are MeSH descriptors whose meaning is more specific than "Naltrexone".
This graph shows the total number of publications written about "Naltrexone" by people in this website by year, and whether "Naltrexone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naltrexone" by people in Profiles.
-
Stancil SL, Voss M, Nolte W, Tumberger J, Adelman W, Abdel-Rahman S. Effects of genotype and food on naltrexone exposure in adolescents. Clin Transl Sci. 2022 11; 15(11):2732-2743.
-
Stancil SL, Nolte W, Pearce RE, Staggs VS, Leeder JS. The Impact of Age and Genetics on Naltrexone Biotransformation. Drug Metab Dispos. 2022 02; 50(2):168-173.
-
Stancil SL, Adelman W, Dietz A, Abdel-Rahman S. Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program. J Child Adolesc Psychopharmacol. 2019 11; 29(9):721-724.